Treadmill workstations in office workers who are overweight or obese: a randomised controlled trial

被引:36
|
作者
Bergman, Frida [1 ]
Wahlstrom, Viktoria [1 ]
Stomby, Andreas [1 ]
Otten, Julia [1 ]
Lanthen, Ellen [1 ]
Renklint, Rebecka [1 ]
Waling, Maria [3 ]
Sorlin, Ann [2 ]
Boraxbekk, Carl-Johan [4 ,6 ]
Wennberg, Patrik [1 ]
Ohberg, Fredrik [5 ]
Levine, James A. [7 ,8 ]
Olsson, Tommy [1 ]
机构
[1] Umea Univ, Dept Publ Hlth & Clin Med, S-90185 Umea, Sweden
[2] Umea Univ, Dept Community Med & Rehabil, Umea, Sweden
[3] Umea Univ, Dept Food & Nutr, Umea, Sweden
[4] Umea Univ, Ctr Demog & Aging Res, Umea, Sweden
[5] Umea Univ, Dept Radiat Sci, Umea, Sweden
[6] Copenhagen Univ Hosp, Danish Res Ctr Magnet Resonance, Ctr Funct & Diagnost Imaging & Res, Hvidovre, Denmark
[7] Mayo Clin, Dept Endocrinol, Rochester, MN USA
[8] Fdn IPSEN, Paris, France
来源
LANCET PUBLIC HEALTH | 2018年 / 3卷 / 11期
关键词
PHYSICAL-ACTIVITY; SITTING TIME; SEDENTARY BEHAVIOR; ADULTS; MORTALITY; DISEASE; RISK;
D O I
10.1016/S2468-2667(18)30163-4
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Background Treadmill workstations that enable office workers to walk on a treadmill while working at their computers might increase physical activity in offices, but long-term effects are unknown. We therefore investigated whether treadmill workstations in offices increased daily walking time. Methods We did a randomised controlled trial of healthy office workers who were either overweight or obese. We recruited participants from 13 different companies, which comprised 17 offices, in Umea, Sweden. We included people who were aged 40-67 years, had sedentary work tasks, and had a body-mass index (BMI) between 25 kg/m(2) and 40 kg/m(2). After the baseline measurement, we stratified participants by their BMI (25-30 kg/m(2) and >30 to 40 kg/m(2)); subsequently, an external statistician randomly assigned these participants (1: 1) to either the intervention group (who received treadmill workstations for optional use) or the control group (who continued to work at their sit-stand desks as usual). Participants in the intervention group received reminders in boosting emails sent out to them at four occasions during the study period. Researchers were masked to group assignment until after analysis of the primary outcome. After the baseline measurement, participants were not masked to group belongings. The primary outcome was total daily walking time at weekdays and weekends, measured at baseline, 2 months, 6 months, 10 months, and 13 months with the accelerometer activPAL (PAL Technologies, Glasgow, UK), which was worn on the thigh of participants for 24 h a day for 7 consecutive days. We used an intention-to-treat approach for our analyses. This trial is registered with ClinicalTrials.gov, number NCT01997970, and is closed to new participants. Findings Between Nov 1, 2013, and June 30, 2014, a total of 80 participants were recruited and enrolled (n=40 in both the intervention and control groups). Daily walking time during total time awake at weekdays increased between baseline and 13 months by 18 min (95% CI 9 to 26) in the intervention group and 1 min (-7 to 9) in the control group (difference 22 min [95% CI 7 to 37], p(interaction) = 0.00045); for weekend walking, the change from baseline to 13 months was 5 min (-8 to 18) in the intervention group and 8 min (-5 to 21) in the control group (difference -1 min [-19 to 17]; p(interaction) = 0.00045). Neither measure met our predetermined primary outcome of 30 min difference in total walking time between the intervention and control group, so the primary outcome of the trial was not met. One adverse event was reported in a participant who accidently stepped on their Achilles tendon. Interpretation In a sedentary work environment, treadmill workstations result in a statistically significant but smaller-than-expected increase in daily walking time. Future studies need to investigate how increasing physical activity at work might have potentially compensatory effects on non-work activity. Copyright (c) 2018 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY-NC-ND 4.0 license.
引用
收藏
页码:E523 / E535
页数:13
相关论文
共 50 条
  • [41] Oxyntomodulin increases energy expenditure in addition to decreasing energy intake in overweight and obese humans: a randomised controlled trial
    Wynne, K.
    Park, A. J.
    Small, C. J.
    Meeran, K.
    Ghatei, M. A.
    Frost, G. S.
    Bloom, S. R.
    INTERNATIONAL JOURNAL OF OBESITY, 2006, 30 (12) : 1729 - 1736
  • [42] Treatment Acceptability and Psychosocial Outcomes of a Randomised Controlled Trial of a Cognitive Behavioural Lifestyle Intervention for Overweight and Obese Adolescents
    Brennan, Leah
    Wilks, Ray
    Walkley, Jeff
    Fraser, Steve F.
    Greenway, Kate
    BEHAVIOUR CHANGE, 2012, 29 (01) : 36 - 62
  • [43] Lifestyle interventions for knee pain in overweight and obese adults aged ≥45: economic evaluation of randomised controlled trial
    Barton, Garry R.
    Sach, Tracey H.
    Jenkinson, Claire
    Doherty, Michael
    Avery, Anthony J.
    Muir, Kenneth R.
    BMJ-BRITISH MEDICAL JOURNAL, 2009, 339 : 610 - 612
  • [44] Outcomes and costs of primary care surveillance and intervention for overweight or obese children: the LEAP 2 randomised controlled trial
    Wake, Melissa
    Baur, Louise A.
    Gerner, Bibi
    Gibbons, Kay
    Gold, Lisa
    Gunn, Jane
    Levickis, Penny
    McCallum, Zoe
    Naughton, Geraldine
    Sanci, Lena
    Ukoumunne, Obioha C.
    BMJ-BRITISH MEDICAL JOURNAL, 2009, 339 : 1132
  • [45] Conventional versus reverse insertion of i-gel® in overweight and obese patients - Interventional randomised controlled trial
    Ahuja, Sonali
    Kaur, Gurpreeti
    Garg, Kamakshi
    Grewal, Anju
    INDIAN JOURNAL OF ANAESTHESIA, 2023, 67 (08) : 708 - 713
  • [46] Author Correction: Effect of carnosine supplementation on the plasma lipidome in overweight and obese adults: a pilot randomised controlled trial
    Estifanos Baye
    Jozef Ukropec
    Maximilian P. J. de Courten
    Silvia Vallova
    Patrik Krumpolec
    Timea Kurdiova
    Giancarlo Aldini
    Barbara Ukropcova
    Barbora de Courten
    Scientific Reports, 10
  • [47] Antenatal dietary and lifestyle advice for women who are overweight or obese and the effect on fetal growth and adiposity: the LIMIT randomised trial
    Grivell, R. M.
    Yelland, L. N.
    Deussen, A.
    Crowther, C. A.
    Dodd, J. M.
    BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 2016, 123 (02) : 233 - 243
  • [48] The effects of antenatal dietary and lifestyle advice for women who are overweight or obese on neonatal health outcomes: the LIMIT randomised trial
    Dodd, Jodie M.
    McPhee, Andrew J.
    Turnbull, Deborah
    Yelland, Lisa N.
    Deussen, Andrea R.
    Grivell, Rosalie M.
    Crowther, Caroline A.
    Wittert, Gary
    Owens, Julie A.
    Robinson, Jeffrey S.
    BMC MEDICINE, 2014, 12
  • [49] The effects of antenatal dietary and lifestyle advice for women who are overweight or obese on neonatal health outcomes: the LIMIT randomised trial
    Jodie M Dodd
    Andrew J McPhee
    Deborah Turnbull
    Lisa N Yelland
    Andrea R Deussen
    Rosalie M Grivell
    Caroline A Crowther
    Gary Wittert
    Julie A Owens
    Jeffrey S Robinson
    BMC Medicine, 12
  • [50] Effect of metformin in addition to dietary and lifestyle advice for pregnant women who are overweight or obese: the GRoW randomised, double-blind, placebo-controlled trial
    Dodd, Jodie M.
    Louise, Jennie
    Deussen, Andrea R.
    Grivell, Rosalie M.
    Dekker, Gustaaf
    McPhee, Andrew J.
    Hague, William
    LANCET DIABETES & ENDOCRINOLOGY, 2019, 7 (01): : 15 - 24